PubMed=8097673
Maeda O., Terasawa M., Ishikawa T., Oguchi H., Mizuno K., Kawai M., Kikkawa F., Tomoda Y., Hidaka H.
A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells.
Cancer Res. 53:2051-2056(1993)

PubMed=8978593; DOI=10.1159/000227661
Wakahara Y., Nawa A., Okamoto T., Hayakawa A., Kikkawa F., Suganama N., Wakahara F., Tomoda Y.
Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro.
Oncology 54:48-54(1997)

PubMed=9344045; DOI=10.1023/A:1018495414975
Shibata K., Kikkawa F., Nawa A., Tamakoshi K., Suganuma N., Tomoda Y.
Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.
Clin. Exp. Metastasis 15:612-619(1997)

PubMed=12767062; DOI=10.1002/ijc.11177
Kikkawa F., Kajiyama H., Ino K., Shibata K., Mizutani S.
Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.
Int. J. Cancer 105:779-783(2003)